Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.67%
0%
8.67%
6 Months
0.59%
0%
0.59%
1 Year
-11.48%
0%
-11.48%
2 Years
-5.68%
0%
-5.68%
3 Years
29.19%
0%
29.19%
4 Years
-2.61%
0%
-2.61%
5 Years
-13.18%
0%
-13.18%
Novonesis (Novozymes A/S) for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.49%
EBIT Growth (5y)
11.88%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
69.53%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
2.01
EV to EBIT
28.91
EV to EBITDA
16.92
EV to Capital Employed
1.80
EV to Sales
5.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.22%
ROE (Latest)
5.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 4 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
8,362.00
7,443.00
12.35%
Operating Profit (PBDIT) excl Other Income
3,123.50
2,669.20
17.02%
Interest
64.20
125.50
-48.84%
Exceptional Items
-48.60
-114.30
57.48%
Consolidate Net Profit
1,487.40
917.10
62.19%
Operating Profit Margin (Excl OI)
239.80%
181.30%
5.85%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 12.35% vs -6.35% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 62.19% vs -10.96% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
31,029.40
28,593.20
8.52%
Operating Profit (PBDIT) excl Other Income
10,917.30
8,797.60
24.09%
Interest
601.50
653.40
-7.94%
Exceptional Items
-509.00
-1,283.70
60.35%
Consolidate Net Profit
4,355.60
2,280.90
90.96%
Operating Profit Margin (Excl OI)
208.30%
165.70%
4.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 8.52% vs 59.75% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 90.96% vs -24.95% in Dec 2024






